MARA-logo-FC-TM.png
MARA Schedules Conference Call for Second Quarter 2024 Financial Results
18 juil. 2024 08h05 HE | Marathon Digital Holdings Inc.
Earnings Webcast and Conference Call Set for Thursday, August 1, 2024 at 5:00 p.m. ET Fort Lauderdale, FL, July 18, 2024 (GLOBE NEWSWIRE) -- MARA (NASDAQ: MARA) ("MARA" or the "Company"), a global...
logo.png
Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment
03 juil. 2024 09h00 HE | Autonomix Medical, Inc.
Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses preliminary positive results from the first five “lead-in” patients in the Company’s ongoing human clinical trial THE...
Logo.jpg
Global Tech Industries Group, Inc. Reaffirms Commitment to Shareholder Value and Continued Vigilance Against Noncompliant Trading Activities
14 juin 2024 09h25 HE | Global Tech Industries Group, Inc.
New York, NY, June 14, 2024 (GLOBE NEWSWIRE) -- (OTC: GTII) Global Tech Industries Group, Inc. (“GTII” or “The Company”), www.gtii-us.com, announced today that GTII’s management is taking steps in...
logo.png
Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer
23 mai 2024 09h15 HE | Autonomix Medical, Inc.
Results from the preclinical study demonstrated statistically significant reduction of metastases and statistically significant reduction in tumor mass Lori Bisson, Chief Executive Officer...
logo.png
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series
14 mai 2024 16h15 HE | Autonomix Medical, Inc.
Live webcast on Thursday, May 16th at 4:00 PM ET THE WOODLANDS, TX, May 14, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company...
logo.png
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity
23 févr. 2024 08h50 HE | Autonomix Medical, Inc.
Live webcast with Lori Bisson, Chief Executive Officer of Autonomix, on Thursday, February 29th at 12:00 PM ET THE WOODLANDS, TX, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ:...
logo.png
Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use
30 janv. 2024 09h05 HE | Autonomix Medical, Inc.
Autonomix now wholly owns development and commercialization rights to its technology in all indications Re-acquisition broadens Autonomix’s development and strategic opportunities THE WOODLANDS,...
logo.png
Autonomix Medical, Inc. Announces Closing of $11.2 Million in Gross Proceeds from Initial Public Offering
26 janv. 2024 16h05 HE | Autonomix Medical, Inc.
Shares to begin trading on NASDAQ on January 29, 2024 under the ticker symbol “AMIX” THE WOODLANDS, TX., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the...
logo.png
Autonomix Medical, Inc. Completes Formation of Engineering Development Team and Provides Project Update
11 janv. 2024 10h00 HE | Autonomix Medical, Inc.
Appointment of Marco Bedoya, a proven leader in medical device mechanical engineering, as Director of Product Development Engagements secured with preeminent firms to drive design and development...
logo.png
Autonomix Medical, Inc. to Participate in the Virtual Investor Fireside Chat
14 déc. 2023 10h15 HE | Autonomix Medical, Inc.
Live moderated video webcast on Tuesday, December 19th at 3:00 PM ET THE WOODLANDS, TX, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device...